| 000 | 01557 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515060126.0 | ||
| 264 | 0 | _c20070316 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a1176-6344 | ||
| 024 | 7 |
_a10.2147/vhrm.2005.1.4.351 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatel, Jeetesh V | |
| 245 | 0 | 0 |
_aEfficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study. _h[electronic resource] |
| 260 |
_bVascular health and risk management _c2005 |
||
| 300 |
_a351-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAsia _xethnology |
| 650 | 0 | 4 | _aAsian People |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 |
_aDyslipidemias _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeptanoic Acids _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPyrroles _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aGupta, Sandeep | |
| 700 | 1 | _aLie, Frank | |
| 700 | 1 | _aHughes, Elizabeth A | |
| 773 | 0 |
_tVascular health and risk management _gvol. 1 _gno. 4 _gp. 351-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/vhrm.2005.1.4.351 _zAvailable from publisher's website |
| 999 |
_c16873893 _d16873893 |
||